<DOC>
	<DOC>NCT00048360</DOC>
	<brief_summary>This is a placebo controlled study evaluating the efficacy and safety of medication in adults with Attention-Deficit Hyperactivity Disorder (ADHD).</brief_summary>
	<brief_title>Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Inclusion criteria: Patient must be diagnosed with ADHD. Patient has a current or past history of seizure disorder, brain injury, anorexia nervosa or bulimia. Patient has a current diagnosis of Major Depressive Disorder (MDD). Patient has a current primary diagnosis of, or received treatment for, Panic Disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD) or Acute Stress Disorder within the previous 12 months. Patient has a lifetime diagnosis of bipolar disorder, schizophrenia or other psychotic disorders. Patient has a positive urine test at screening for presence of illicit drugs or alcohol abuse during the past 12 months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>ADD</keyword>
	<keyword>ADHD</keyword>
	<keyword>attention deficit</keyword>
	<keyword>hyperactivity</keyword>
</DOC>